Ninety One (UK)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-415,302
Closed -$46.6M 244
2020
Q2
$46.6M Sell
415,302
-1,353,569
-77% -$152M 0.17% 103
2020
Q1
$159M Sell
1,768,871
-176,515
-9% -$15.8M 0.67% 44
2019
Q4
$210M Sell
1,945,386
-58,896
-3% -$6.37M 0.7% 45
2019
Q3
$196M Buy
2,004,282
+1,355,775
+209% +$133M 0.76% 38
2019
Q2
$221M Sell
648,507
-1,024,997
-61% -$350M 0.84% 36
2019
Q1
$226M Buy
1,673,504
+240,014
+17% +$32.4M 0.9% 28
2018
Q4
$140M Buy
1,433,490
+66,288
+5% +$6.45M 0.6% 58
2018
Q3
$190M Buy
1,367,202
+818,204
+149% +$114M 0.71% 47
2018
Q2
$68.2M Buy
548,998
+82,961
+18% +$10.3M 0.34% 84
2018
Q1
$51.9M Sell
466,037
-237,166
-34% -$26.4M 0.28% 89
2017
Q4
$84.1M Buy
+703,203
New +$84.1M 0.35% 77